Accessibility: Skip TopNav
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
Xenon MRI continues to evolve into a practical cardiopulmonary biomarker platform for clinical trials and therapeutic development
Format
PNG
Quelle:
Polarean
Downloads
Originalgröße
Groß
Mittel
Klein